700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Authors :: W-H. Fridman
Nathalie Chaput
Diether Lambrechts
Eduard Roussel
Bernard Escudier
Yann-Alexandre Vano
N. Rioux Leclercq
Laurence Albiges
M. Meylan
C. Dalban
B. Laguerre
Annelies Verbiest
Benoit Beuselinck
Christine Chevreau
Stéphane Terry
Sylvie Chabaud
Florence Tantot
Catherine Sautès-Fridman
Marine Gross-Goupil
Aude Flechon
Source :: Annals of Oncology. 31:S553
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: 0303 health sciences
Kidney
Effector
Angiogenesis
business.industry
Hematology
Predictive value
03 medical and health sciences
0302 clinical medicine
Immune system
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Cancer research
medicine
Nivolumab
business
030304 developmental biology

Full Text Access

Tools